Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

MET alterations may provide a potential biomarker to evaluate patients who will benefit from treatment with MET inhibitors. Therefore, the purpose of the present study is to investigate the utility of a liquid biopsy-based strategy to assess MET alterations in cancer patients. We analyzed <i>MET</i>...

Полное описание

Библиографические подробности

Главные авторы:	Patricia Mondelo-Macía, Carmela Rodríguez-López, Laura Valiña, Santiago Aguín, Luis León-Mateos, Jorge García-González, Alicia Abalo, Oscar Rapado-González, Mercedes Suárez-Cunqueiro, Angel Díaz-Lagares, Teresa Curiel, Silvia Calabuig-Fariñas, Aitor Azkárate, Antònia Obrador-Hevia, Ihab Abdulkader, Laura Muinelo-Romay, Roberto Diaz-Peña, Rafael López-López
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2020-02-01
Серии:	Cells
Предметы:	met protein expression <i>met</i> amplification circulating free dna (cfdna) circulating tumor cells (ctcs) targeted therapy <i>met</i> copy number
Online-ссылка:	https://www.mdpi.com/2073-4409/9/2/522
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!